Clinical Trials in Lethbridge, Alberta

Find clinical trials in Lethbridge, Alberta. Discover local research opportunities and treatment options in your area.

11 Active Trials Found in Lethbridge

Showing 11 trials on this page

Page 1 of 1

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

NCT ID: NCT05702034

The LIBREXIA-STROKE trial is studying a new medication called milvexian to see if it can help prevent another ischemic stroke in people who have recently experienced one or a high-risk transient is...

Recruiting

Phase: PHASE3 Conditions: Ischemic Stroke; Ischemic Attack, Transient

A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

NCT ID: NCT06052059

This clinical trial is studying a new medication called tulisokibart (MK-7240) to see if it is effective and safe for people with moderately to severely active ulcerative colitis, a condition that ...

Recruiting

Phase: PHASE3 Conditions: Ulcerative Colitis

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

NCT ID: NCT06430801

This clinical trial is studying a new medication called tulisokibart, which is being tested for its effectiveness and safety in treating people with moderate to severe Crohn's disease. Crohn's dise...

Recruiting

Phase: PHASE3 Conditions: Crohn's Disease

Alberta Collaborative QI Strategies to Improve Outcomes of Moderate and Late Preterm Infants (ABC-QI Trial)

NCT ID: NCT05231200

The ABC-QI Trial is a study focused on improving the care of preterm infants born between 32 and 36 weeks of pregnancy who need extra help in the hospital. The goal of the trial is to find out if u...

Recruiting

Phase: NA Conditions: Length of Stay

Optimizing the Management of Staphylococcus Aureus Bacteremia (OPTIMUS-SAB)

NCT ID: NCT06338176

The OPTIMUS-SAB clinical trial is focused on improving the care of patients with Staphylococcus aureus bacteremia (SAB), a serious bloodstream infection that can lead to significant health risks, e...

Recruiting

Phase: NA Conditions: Staph Aureus Bacteremia

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures

NCT ID: NCT05614063

The X-TOLE2 Phase 3 clinical trial is testing a new medication called XEN1101 to see how well it helps people with focal-onset seizures, which are a type of seizure that starts in one specific area...

Recruiting

Phase: PHASE3 Conditions: Focal Onset Seizures

A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

NCT ID: NCT05667142

This clinical trial is studying a medication called XEN1101 to see if it can help reduce the frequency of primary generalized tonic-clonic seizures (PGTCS) in people who are already taking other se...

Recruiting

Phase: PHASE3 Conditions: Primary Generalized Tonic-Clonic Seizures

An Open-label Study of XEN1101 in Epilepsy

NCT ID: NCT05718817

This is a long-term, open-label extension study called X-TOLE4, asking how safe and tolerable XEN1101 is when used for epilepsy over up to 3 years, and how it works in the body and on seizures afte...

Enrolling by invitation

Phase: PHASE3 Conditions: Focal Epilepsy, Tonic-Clonic Seizures

Phase IIa Study Evaluating AZD7798 in Crohn's Disease

NCT ID: NCT06450197

This clinical trial is studying a new treatment called AZD7798 for people with moderate to severe Crohn's disease, which is a chronic condition that causes inflammation in the digestive tract. The ...

Recruiting

Phase: PHASE2 Conditions: Moderate to Severe Crohn's Disease

Contingency Management as an Adjunct Treatment for Rural and Remote Disordered Gamblers

NCT ID: NCT02953899

This clinical trial is exploring a new way to help people with gambling problems, especially those living in rural or remote areas. The study is testing a method called contingency management, whic...

Recruiting

Phase: NA Conditions: Gambling Disorder

Dialyzing Wisely - Improving the Delivery of Acute Renal Replacement Therapy to Albertans

NCT ID: NCT05186636

The "Dialyzing Wisely" clinical trial is focused on improving the way acute renal replacement therapy (RRT) is delivered to patients with acute kidney injury in Alberta. The goal is to use the best...

Recruiting

Conditions: Acute Renal Injury